Red Yeast Rice

Red Yeast Rice supports cardiovascular function while helping maintain blood lipids and cholesterol that begin in the healthy range. Xymogen uses ANKASCIN® 568-R, a patented extract produced by fermenting non-GMO rice with Monascus purpureus. The label supplies 110 mg per serving, with monascin at 2.8% and ankaflavin at 0.9%. These two constituents distinguish the formula from products defined by monacolin K. Xymogen says independent testing found neither monacolin K nor citrinin in the finished ingredient. The result is a focused fermented-rice capsule whose stated benefits concern ordinary cardiovascular and lipid metabolism. Those manufacturer-supported roles do not turn it into a substitute for monitoring, prescribed care, diet, exercise, or individualized guidance from a qualified healthcare professional.

Adults seeking practitioner-guided cardiovascular nutrition may consider Red Yeast Rice when their goal is support for blood lipids and cholesterol already in a healthy range. The active is 110 mg of Monascus purpureus-fermented rice extract, standardized for monascin and ankaflavin and tested by Xymogen for the absence of detected monacolin K and citrinin. Medication users should have a professional review before beginning, particularly because the name may be confused with other red yeast rice preparations that have different constituent profiles. The product is not intended during pregnancy or lactation. Its inactive materials are dicalcium phosphate dihydrate, hypromellose, water, ascorbyl palmitate, and silica. Xymogen excludes dairy and animal materials; it separately names sesame, fish, gluten, tree nuts, soy, egg, peanuts, shellfish, wheat, and genetically modified ingredients.

Red Yeast Rice should be reviewed carefully because fermented-rice products are not interchangeable and medication use can change their suitability. Xymogen states: Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professional. Not intended for use if you are pregnant or lactating. Do not use if tamper seal is damaged. ANKASCIN® 568-R supplies 110 mg; its standardized concentrations are 2.8% for monascin and 0.9% for ankaflavin. Xymogen’s finished-ingredient testing finds neither monacolin K nor citrinin. Anyone sensitive to Monascus purpureus or to dicalcium phosphate, hypromellose, ascorbyl palmitate, or silica should inspect the composition before use. An unexpected response warrants stopping the capsules and seeking guidance from the professional managing the regimen. Store them closed, cool, dry, and away from children.

Red Yeast Rice supports overall health through a standardized fermentation product used for normal cardiovascular and lipid metabolism. Monascus purpureus grows on non-GMO rice to create a complex extract containing pigments, sterols, isoflavones, fatty acids, and other fermentation constituents discussed by Xymogen. Monascin accounts for 2.8% of ANKASCIN® 568-R; ankaflavin accounts for 0.9%, and a serving supplies 110 mg. Xymogen links that composition to maintenance of healthy blood lipid and cholesterol levels that are already within the normal range. Independent analysis, the manufacturer says, returns nondetectable results for both citrinin and monacolin K—an important product-specific distinction rather than a general statement about all red yeast rice. By defining the exact extract and its marker compounds, the formula supports a clearly bounded cardiovascular role without extending into disease prevention or treatment language.